Core Biogenesis
Paris
About Core Biogenesis
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies. The company uses proprietary gene editing and plant biotechnology to drastically reduce the cost of making growth factors. The growth factors are molecules used in the clean meat and cell therapy industries.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $26.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2022)
- Website: corebiogenesis.com
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/core-biogenesis-75358 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.